AL-OTAIBI, F. A., C. HAMANI und A. M. LOZANO (2011).
Neuromodulation in epilepsy.
Neurosurgery 69: 957-979.
ALEXANDER, G. E. und M. D. CRUTCHER (1990).
Functional architecture of basal ganglia circuits: neural substrates of parallel processing.
Trends Neurosci 13: 266-271.
ALVAREZ-DOLADO, M., M. E. CALCAGNOTTO, K. M. KARKAR, D. G. SOUTHWELL, D. M.
JONES-DAVIS, R. C. ESTRADA, J. L. RUBENSTEIN, A. ALVAREZ-BUYLLA und S. C.
BARABAN (2006).
Cortical inhibition modified by embryonic neural precursors grafted into the postnatal brain.
J Neurosci 26: 7380-7389.
AMARAL, D. G. (1978).
A Golgi study of cell types in the hilar region of the hippocampus in the rat.
J Comp Neurol 182: 851-914.
ANDERSON, S. A. und S. C. BARABAN (2012).
Cell Therapy Using GABAergic Neural Progenitors. in: Jasper's Basic Mechanisms of the Epilepsies.
Noebels, J.L., M. Avoli, M.A. Rogawski, R.W. Olsen, A.V. Delgado-Escueta. Bethesda (MD):
National Center for Biotechnology Information (US). 4th ed. NCBI Bookshelf Online Book Version.
ANDERSON, S. A., D. D. EISENSTAT, L. SHI und J. L. RUBENSTEIN (1997).
Interneuron migration from basal forebrain to neocortex: dependence on Dlx genes.
Science 278: 474-476.
ANDERSON, S. A., O. MARIN, C. HORN, K. JENNINGS und J. L. RUBENSTEIN (2001).
Distinct cortical migrations from the medial and lateral ganglionic eminences.
Development 128: 353-363.
ANDO, S., S. KOBAYASHI, H. WAKI, K. KON, F. FUKUI, T. TADENUMA, M. IWAMOTO, Y.
TAKEDA, N. IZUMIYAMA, K. WATANABE und H. NAKAMURA (2002).
Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine.
J Neurosci Res 70: 519-527.
ANDRES, R. H., A. D. DUCRAY, A. W. HUBER, A. PÉREZ-BOUZA, S. H. KREBS, U.
SCHLATTNER, R. W. SEILER, T. WALLIMANN und H. R. WIDMER (2005).
Effects of creatine treatment on survival and differentiation of GABA-ergic neurons in cultured striatal tissue.
J Neurochem 95: 33-45.
ANDREWS, P. W. (1984).
Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro.
Dev Biol 103: 285-293.
161
ANDREWS, P. W., I. DAMJANOV, D. SIMON, G. S. BANTING, C. CARLIN, N. C. DRACOPOLI und J. FOGH (1984).
Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2.
Differentiation in vivo and in vitro.
Lab Invest 50: 147-162.
ANSCHEL, D. J., E. ORTEGA und R. S. FISHER (2004).
Diazepam prophylaxis for bicuculline-induced seizures: a rat dose-response model.
Neurosci Lett 356: 66-68.
ANTONUCCI, F., Y. BOZZI und M. CALEO (2009).
Intrahippocampal infusion of botulinum neurotoxin E (BoNT/E) reduces spontaneous recurrent seizures in a mouse model of mesial temporal lobe epilepsy.
Epilepsia 50: 963-966.
ARONIADOU-ANDERJASKA,V., F. QASHU und M.F. BRAGA (2007).
Mechanisms regulating GABAergic inhibitory transmission in the basolateral amygdala: implications for epilepsy and anxiety disorders.
FROTSCHER, R. D. TRAUB, M. BOTH und A. DRAGUHN (2011).
Cellular correlate of assembly formation in oscillating hippocampal networks in vitro.
Proc Natl Acad Sci U S A. 108: E607-617.
BANCILA, V., I. NIKONENKO, Y. DUNANT und A. BLOC (2004).
Zinc inhibits glutamate release via activation of pre-synaptic K channels and reduces ischaemic damage in rat hippocampus.
J Neurochem 90: 1243-1250.
BANERJEE, P. N. und R. A. HAUSER (2008).
Incidence and Prevalence. in: Epilepsy: a comprehensive textbook. Engel, J.J. and T.A. Pedley.
Lippincott Williams & Wilkins, Philadelphia: 48-56.
BANKSTAHL, M., J. P. BANKSTAHL, P. BLOMS-FUNKE und W. LÖSCHER (2012).
Striking differences in proconvulsant-induced alterations of seizure threshold in two rat models.
Neurotoxicology 33: 127-137.
BARABAN, S. C., D. G. SOUTHWELL, R. C. ESTRADA, D. L. JONES, J. Y. SEBE, C. ALFARO-CERVELLO, J. M. GARCIA-VERDUGO, J. L. RUBENSTEIN und A. ALVAREZ-BUYLLA (2009).
Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice.
Proc Natl Acad Sci U S A 106: 15472-15477.
BELL, M. S., L. C. VERMEULEN und K. B. SPERLING (2000).
Pharmacotherapy with botulinum toxin: harnessing nature's most potent neurotoxin.
Pharmacotherapy 20: 1079-1091.
162 BEN-MENACHEM, E. (2002).
Vigabatrin. in: Antiepileptic drugs. Levy R.H., R.H. Mattson, B.S. Meldrum and E. Perucca.
Lippincott Williams & Wilkins, Philadelphia: 855-863.
BEN-MENACHEM, E. (2007).
Weight issues for people with epilepsy - a review.
Epilepsia 48: 42-45.
BEN-MENACHEM, E., A. HAMBERGER und J. MUMFORD (1993).
Effect of long-term vigabatrin therapy on GABA and other amino acid concentrations in the central nervous system--a case study.
Epilepsy Res 16: 241-243.
BENABID, A. L. (2007).
What the future holds for deep brain stimulation.
Expert Rev Med Devices 4: 895-903.
BENABID, A. L., A. KOUDSIE, A. BENAZZOUZ, L. VERCUEIL, V. FRAIX, S. CHABARDES, J.
F. LEBAS und P. POLLAK (2001).
Deep brain stimulation of the corpus luysi (subthalamic nucleus) and other targets in Parkinson's disease. Extension to new indications such as dystonia and epilepsy.
J Neurol 248: III37-47.
BENABID, A. L., A. KOUDSIE, P. POLLAK, P. KAHANE, S. CHABARDES, E. HIRSCH, C.
MARESCAUX und A. BENAZZOUZ (2000a).
Future prospects of brain stimulation.
Neurol Res 22: 237-246.
BENABID, A. L., P. P. KRACK, A. BENAZZOUZ, P. LIMOUSIN, A. KOUDSIE und P. POLLAK (2000b).
Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: methodologic aspects and clinical criteria.
Neurology 55: S40-44.
BERENDT, M., H. GREDAL, A. K. ERSBOLL und J. ALVING (2007).
Premature death, risk factors, and life patterns in dogs with epilepsy.
J Vet Intern Med 21: 754-759.
BERG, A. T., S. F. BERKOVIC, M. J. BRODIE, J. BUCHHALTER, J. H. CROSS, W. VAN EMDE BOAS, J. ENGEL, J. FRENCH, T. A. GLAUSER, G. W. MATHERN, S. L. MOSHÉ, D. NORDLI, P.
PLOUIN und I. E. SCHEFFER (2010).
Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009.
Epilepsia 51: 676-685.
BERGEY, G. K., H. BIGALKE und P. G. NELSON (1987).
Differential effects of tetanus toxin on inhibitory and excitatory synaptic transmission in mammalian spinal cord neurons in culture: a presynaptic locus of action for tetanus toxin.
J Neurophysiol 57: 121-131.
163 BJÖRKLUND, A. und O. LINDVALL (2000).
Cell replacement therapies for central nervous system disorders.
Nat Neurosci 3: 537-544.
BLOMS-FUNKE, P. und W. LÖSCHER (1996).
The anticonvulsant gabapentin decreases firing rates of substantia nigra pars reticulata neurons.
Eur J Pharmacol 316: 211-218.
BOISON, D. (2007).
Cell and gene therapies for refractory epilepsy.
Curr Neuropharmacol 5: 115-125.
BOLAM, J. P., J. J. HANLEY, P. A. BOOTH und M. D. BEVAN (2000).
Synaptic organisation of the basal ganglia.
J Anat 196: 527-542.
BOON, P., R. RAEDT, V. DE HERDT, T. WYCKHUYS und K. VONCK (2009).
Electrical stimulation for the treatment of epilepsy.
Neurotherapeutics 6: 218-227.
BORLONGAN, C. V., S. SAPORTA, S. G. POULOS, A. OTHBERG und P. R. SANBERG (1998a).
Viability and survival of hNT neurons determine degree of functional recovery in grafted ischemic rats.
Neuroreport 9: 2837-2842.
BORLONGAN, C. V., Y. TAJIMA, J. Q. TROJANOWSKI, V. M. LEE und P. R. SANBERG (1998b).
Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats.
Exp Neurol 149: 310-321.
BORTEL, A., M. LEVESQUE, G. BIAGINI, J. GOTMAN und M. AVOLI (2010).
Convulsive status epilepticus duration as determinant for epileptogenesis and interictal discharge generation in the rat limbic system.
Neurobiol Dis 40: 478-489.
BOUILLERET, V., F. LOUP, T. KIENER, C. MARESCAUX und J. M. FRITSCHY (2000).
Early loss of interneurons and delayed subunit-specific changes in GABA(A)-receptor expression in a mouse model of mesial temporal lobe epilepsy.
Hippocampus 10: 305-324.
BRAGANZA, O., P. BEDNER, K. HUTTMANN, E. VON STADEN, A. FRIEDMAN, G. SEIFERT und C. STEINHAUSER (2012).
Albumin is taken up by hippocampal NG2 cells and astrocytes and decreases gap junction coupling.
Epilepsia 53: 1898-1906.
164
BREDERLAU, A., A. S. CORREIA, S. V. ANISIMOV, M. ELMI, G. PAUL, L. ROYBON, A.
MORIZANE, F. BERGQUIST, I. RIEBE, U. NANNMARK, M. CARTA, E. HANSE, J.
TAKAHASHI, Y. SASAI, K. FUNA, P. BRUNDIN, P. S. ERIKSSON und J. Y. LI (2006).
Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease:
effect of in vitro differentiation on graft survival and teratoma formation.
Stem Cells 24: 1433-1440.
BREWER, G. J. und T. W. WALLIMANN (2000).
Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons.
J Neurochem 74: 1968-1978.
BRODIE, M. J. (2010).
Antiepileptic drug therapy the story so far.
Seizure 19: 650-655.
BRUNDIN, P., G. BARBIN, O. ISACSON, M. MALLAT, B. CHAMAK, A. PROCHIANTZ, F. H.
GAGE und A. BJÖRKLUND (1985).
Survival of intracerebrally grafted rat dopamine neurons previously cultured in vitro.
Neurosci Lett 61: 79-84.
BRUNDIN, P., G. BARBIN, R. E. STRECKER, O. ISACSON, A. PROCHIANTZ und A.
BJÖRKLUND (1988).
Survival and function of dissociated rat dopamine neurones grafted at different developmental stages or after being cultured in vitro.
Brain Res 467: 233-243.
BRUNDIN, P., O. G. NILSSON, R. E. STRECKER, O. LINDVALL, B. ASTEDT und A.
BJÖRKLUND (1986).
Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease.
Exp Brain Res 65: 235-240.
BUONERBA, C., G. DI LORENZO, A. MARINELLI, P. FEDERICO, G. PALMIERI, M.
IMBIMBO, P. CONTI, G. PELUSO, S. DE PLACIDO und J. H. SAMPSON (2011).
A comprehensive outlook on intracerebral therapy of malignant gliomas.
Crit Rev Oncol Hematol 80: 54-68.
BUZSÁKI, G., F. BAYARDO, R. MILES, R. K. WONG und F. H. GAGE (1989).
The grafted hippocampus: an epileptic focus.
Exp Neurol 105: 10-22.
BUZSÁKI, G., E. MASLIAH, L. S. CHEN, Z. HORVATH, R. TERRY und F. H. GAGE (1991).
Hippocampal grafts into the intact brain induce epileptic patterns.
Brain Res 554: 30-37.
BUZSÁKI, G., G. PONOMAREFF, F. BAYARDO, T. SHAW und F. H. GAGE (1988).
Suppression and induction of epileptic activity by neuronal grafts.
Proc Natl Acad Sci U S A 85: 9327-9330.
165
CALCAGNOTTO, M. E., L. P. RUIZ, M. M. BLANCO, J. G. SANTOS-JUNIOR, M. F. VALENTE, C. PATTI, R. FRUSSA-FILHO, M. F. SANTIAGO, I. ZIPANCIC, M. ALVAREZ-DOLADO, L. E.
MELLO und B. M. LONGO (2010).
Effect of neuronal precursor cells derived from medial ganglionic eminence in an acute epileptic seizure model.
Epilepsia 51: 71-75.
CALEO, M. und G. SCHIAVO (2009).
Central effects of tetanus and botulinum neurotoxins.
Toxicon 54: 593-599.
CAPOGNA, M., R. A. MCKINNEY, V. O'CONNOR, B. H. GAHWILER und S. M. THOMPSON (1997).
Ca2+ or Sr2+ partially rescues synaptic transmission in hippocampal cultures treated with botulinum toxin A and C, but not tetanus toxin.
J Neurosci 17: 7190-7202.
CARPENTINO, J. E., N. W. HARTMAN, L. B. GRABEL und J. R. NAEGELE (2008).
Region-specific differentiation of embryonic stem cell-derived neural progenitor transplants into the adult mouse hippocampus following seizures.
J Neurosci Res 86: 512-524.
CASTILLO, C. G., S. MENDOZA-TREJO, M. B. AGUILAR, W. J. FREED und M. GIORDANO (2008).
Intranigral transplants of a GABAergic cell line produce long-term alleviation of established motor seizures.
Behav Brain Res 193: 17-27.
CASTILLO, C. G., S. MENDOZA, W. J. FREED und M. GIORDANO (2006).
Intranigral transplants of immortalized GABAergic cells decrease the expression of kainic acid-induced seizures in the rat.
Behav Brain Res 171: 109-115.
CASTILLO, C. G., S. MENDOZA, J. SAAVEDRA und M. GIORDANO (2010).
Lack of effect of intranigral transplants of a GABAergic cell line on absence seizures.
Epilepsy Behav 18: 358-365.
Deep brain stimulation in epilepsy with particular reference to the subthalamic nucleus.
Epileptic Disord 4: S83-93.
166
CHADDOCK, J. A., J. R. PURKISS, F. C. ALEXANDER, S. DOWARD, S. J. FOOKS, L. M. FRIIS, Y. H. HALL, E. R. KIRBY, N. LEEDS, H. J. MOULSDALE, A. DICKENSON, G. M. GREEN, W.
RAHMAN, R. SUZUKI, M. J. DUGGAN, C. P. QUINN, C. C. SHONE und K. A. FOSTER (2004).
Retargeted clostridial endopeptidases: inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain.
Mov Disord 19: S42-47.
CLARKE, D. J., P. BRUNDIN, R. E. STRECKER, O. G. NILSSON, A. BJÖRKLUND und O.
LINDVALL (1988).
Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: ultrastructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry.
Exp Brain Res 73: 115-126.
COBOS, I., M. E. CALCAGNOTTO, A. J. VILAYTHONG, M. T. THWIN, J. L. NOEBELS, S. C.
BARABAN und J. L. RUBENSTEIN (2005).
Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition and epilepsy.
Nat Neurosci 8: 1059-1068.
CONEJERO-GOLDBERG, C., C. TORNATORE, W. ABI-SAAB, M. C. MONACO, O. DILLON-CARTER, M. VAWTER, J. ELSWORTH und W. FREED (2000).
Transduction of human GAD67 cDNA into immortalized striatal cell lines using an Epstein-Barr virus-based plasmid vector increases GABA content.
Exp Neurol 161: 453-461.
COSTANTIN, L., Y. BOZZI, C. RICHICHI, A. VIEGI, F. ANTONUCCI, M. FUNICELLO, M.
GOBBI, T. MENNINI, O. ROSSETTO, C. MONTECUCCO, L. MAFFEI, A. VEZZANI und M.
CALEO (2005).
Antiepileptic effects of botulinum neurotoxin E.
J Neurosci 25: 1943-1951.
COULTER, D. A., D. C. MCINTYRE und W. LÖSCHER (2002).
Animal models of limbic epilepsies: what can they tell us?
Brain Pathol 12: 240-256.
CRAMER, J. A. (2012).
Tolerability of antiepileptic drugs: can we determine differences?
Epilepsy Behav 23: 187-192.
CURTIS, M. A., V. F. LOW und R. L. FAULL (2012).
Neurogenesis and progenitor cells in the adult human brain: a comparison between hippocampal and subventricular progenitor proliferation.
Dev Neurobiol 72: 990-1005.
D'HOOGE, R. und P. P. DE DEYN (2001).
Applications of the Morris water maze in the study of learning and memory.
Brain Res Brain Res Rev 36: 60-90.
DE CARLOS, J. A., L. LOPEZ-MASCARAQUE und F. VALVERDE (1996).
Dynamics of cell migration from the lateral ganglionic eminence in the rat.
J Neurosci 16: 6146-6156.
167
DE LANEROLLE, N. C., J. H. KIM, R. J. ROBBINS und D. D. SPENCER (1989).
Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy.
Brain Res 495: 387-395.
DEBINSKI, W. und S. B. TATTER (2009).
Convection-enhanced delivery for the treatment of brain tumors.
Expert Rev Neurother 9: 1519-1527.
DELONG, M. R. (2000).
The basal ganglia. in: Principles of Neural Science. Kandel, E.R., J.H. Schwartz and T. M. Jessel.
McGraw-Hill, New York, 4th ed.: 853-867.
DENIAU, J. M., P. MAILLY, N. MAURICE und S. CHARPIER (2007).
The pars reticulata of the substantia nigra: a window to basal ganglia output.
Prog Brain Res 160: 151-172.
DEPAULIS, A., M. VERGNES und C. MARESCAUX (1994).
Endogenous control of epilepsy: the nigral inhibitory system.
Prog Neurobiol 42: 33-52.
DEPAULIS, A., M. VERGNES, C. MARESCAUX, B. LANNES und J. M. WARTER (1988).
Evidence that activation of GABA receptors in the substantia nigra suppresses spontaneous spike-and-wave discharges in the rat.
Brain Res 448: 20-29.
DERANSART, C., B. T. LE, C. MARESCAUX und A. DEPAULIS (1998).
Role of the subthalamo-nigral input in the control of amygdala-kindled seizures in the rat.
Brain Res. 807: 78-83.
DERANSART, C., C. MARESCAUX und A. DEPAULIS (1996).
Involvement of nigral glutamatergic inputs in the control of seizures in a genetic model of absence epilepsy in the rat.
Neuroscience 71: 721-728.
DICKSON, E. C. (1918).
Botulism: a clinical and experimental study.
Rockefeller Inst. Med. Research, Monog. 8: 1–117.
DONG, M., W. H. TEPP, H. LIU, E. A. JOHNSON und E. R. CHAPMAN (2007).
Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons.
J Cell Biol 179: 1511-1522.
DRESSLER, D. (2012).
Pharmakologie der Botulinumtoxinmedikamente.
HNO 60: 496-504.
DUBÉ, C., S. BOYET, C. MARESCAUX und A. NEHLIG (2000a).
Progressive metabolic changes underlying the chronic reorganization of brain circuits during the silent phase of the lithium-pilocarpine model of epilepsy in the immature and adult Rat.
Exp Neurol 162: 146-157.
168 DUBÉ, C., C. MARESCAUX und A. NEHLIG (2000b).
A metabolic and neuropathological approach to the understanding of plastic changes that occur in the immature and adult rat brain during lithium-pilocarpine-induced epileptogenesis.
Epilepsia 41: S36-43. Clostridium botulinum toxin A endopeptidase fragment and Erythrina cristagalli lectin.
J Biol Chem 277: 34846-34852.
DYBDAL, D. und K. GALE (2000).
Postural and anticonvulsant effects of inhibition of the rat subthalamic nucleus.
J Neurosci 20: 6728-6733.
EATON, M. J., S. Q. WOLFE, M. MARTINEZ, M. HERNANDEZ, C. FURST, J. HUANG, B. R.
FRYDEL und O. GOMEZ-MARIN (2007).
Subarachnoid transplant of a human neuronal cell line attenuates chronic allodynia and hyperalgesia after excitotoxic spinal cord injury in the rat.
J Pain 8: 33-50.
EBERT, U., C. RUNDFELDT, H. LEHMANN und W. LÖSCHER (1999).
Characterization of phenytoin-resistant kindled rats, a new model of drug-resistant partial epilepsy:
influence of experimental and environmental factors.
Epilepsy Res 33: 199-215.
EDER, H. G., D. B. JONES und R. S. FISHER (1997a).
Local perfusion of diazepam attenuates interictal and ictal events in the bicuculline model of epilepsy in rats.
Epilepsia 38: 516-521.
EDER, H. G., A. STEIN und R. S. FISHER (1997b).
Interictal and ictal activity in the rat cobalt/pilocarpine model of epilepsy decreased by local perfusion of diazepam.
Epilepsy Res 29: 17-24.
ENGEL, J. (2006).
Report of the ILAE Classification Core Group.
Epilepsia 47: 1558-1568.
ENGEL, J., JR. und S. L. MOSHÉ (2009).
Commentary: hormones, diet, and botanicals.
Neurotherapeutics 6: 421-423.
169
ENGEL, J., JR., S. WIEBE, J. FRENCH, M. SPERLING, P. WILLIAMSON, D. SPENCER, R.
GUMNIT, C. ZAHN, E. WESTBROOK und B. ENOS (2003).
Practice parameter: temporal lobe and localized neocortical resections for epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons.
Neurology 60: 538-547.
ENGEL, J., L. WOLFSON und L. BROWN (1978).
Anatomical correlates of electrical and behavioral events related to amygdaloid kindling.
Ann. Neurol. 3: 538-544.
ENGEL, J. J., P. C. VAN NESS, T. B. RASMUSSEN und L. M. OJEMANN (1993).
Outcome with respect to epileptic seizures. in: Surgical Treatment of the Epilepsies. Engel, J.J. Raven Press, New York: 603-621.
ERIKSSON, P. S., E. PERFILIEVA, T. BJORK-ERIKSSON, A. M. ALBORN, C. NORDBORG, D.
A. PETERSON und F. H. GAGE (1998).
Neurogenesis in the adult human hippocampus.
Nat Med 4: 1313-1317.
EVERETT, J. W. (1989).
Neurobiology of reproduction in the female rat. A fifty-year perspective.
Monogr Endocrinol 32: 1-133.
FAHRNER, A., G. KANN, A. FLUBACHER, C. HEINRICH, T. M. FREIMAN, J. ZENTNER, M.
FROTSCHER und C. A. HAAS (2007).
Granule cell dispersion is not accompanied by enhanced neurogenesis in temporal lobe epilepsy patients.
Exp Neurol 203: 320-332.
FARRIES, M.A. (2001).
The oscine song system considered in the context of the avian brain: lessons learned from comparative neurobiology.
Brain Behav Evol. 58:80-100.
FASANO, A., A. DANIELE und A. ALBANESE (2012).
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation.
Lancet Neurol 11: 429-442.
FEGER, J. und P. ROBLEDO (1991).
The Effects of Activation or Inhibition of the Subthalamic Nucleus on the Metabolic and Electrophysiological Activities Within the Pallidal Complex and Substantia Nigra in the Rat.
Eur J Neurosci 3: 947-952.
Modulation of experimentally induced epilepsy by intracerebral grafts of fetal GABAergic neurons.
Neuropsychologia 28: 627-634.
170 FINN, D. A. und K. W. GEE (1994).
The estrus cycle, sensitivity to convulsants and the anticonvulsant effect of a neuroactive steroid.
J Pharmacol Exp Ther 271: 164-170.
FISCHER, H. S., I. BERTI, D. S. SCHATZ, C. HUMPEL und A. SARIA (2000).
Retinoic acid treatment enhances the acetylcholine contents in the human teratocarcinoma cell line NTera-2.
Regul Pept 96: 59-63.
FISHER, R., V. SALANOVA, T. WITT, R. WORTH, T. HENRY, R. GROSS, K. OOMMEN, I.
OSORIO, J. NAZZARO, D. LABAR, M. KAPLITT, M. SPERLING, E. SANDOK, J. NEAL, A.
HANDFORTH, J. STERN, A. DESALLES, S. CHUNG, A. SHETTER, D. BERGEN, R. BAKAY, J.
HENDERSON, J. FRENCH, G. BALTUCH, W. ROSENFELD, A. YOUKILIS, W. MARKS, P.
GARCIA, N. BARBARO, N. FOUNTAIN, C. BAZIL, R. GOODMAN, G. MCKHANN, K. BABU KRISHNAMURTHY, S. PAPAVASSILIOU, C. EPSTEIN, J. POLLARD, L. TONDER, J. GREBIN, R. COFFEY und N. GRAVES (2010).
Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy.
Epilepsia 51: 899-908.
FISHER, R. S. und J. HO (2002).
Potential new methods for antiepileptic drug delivery.
CNS Drugs 16: 579-593.
FISHER, R. S., W. VAN EMDE BOAS, W. BLUME, C. ELGER, P. GENTON, P. LEE und J.
ENGEL, JR. (2005).
Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE).
Epilepsia 46: 470-472.
FONNUM, F., Z. GOTTESFELD und I. GROFOVA (1978).
Distribution of glutamate decarboxylase, choline acetyl-transferase and aromatic amino acid decarboxylase in the basal ganglia of normal and operated rats. Evidence for striatopallidal, striatoentopeduncular and striatonigral GABAergic fibres.
Brain Res 143: 125-138.
FÖRSTER, E., S. ZHAO und M. FROTSCHER (2006).
Laminating the hippocampus.
Nat Rev Neurosci 7: 259-267.
FREED, C. R., P. E. GREENE, R. E. BREEZE, W. Y. TSAI, W. DUMOUCHEL, R. KAO, S.
DILLON, H. WINFIELD, S. CULVER, J. Q. TROJANOWSKI, D. EIDELBERG und S. FAHN (2001).
Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
N Engl J Med 344: 710-719.
FRIEDMAN, A., D. KAUFER und U. HEINEMANN (2009).
Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy.
Epilepsy Res 85: 142-149.
171
FUJIKAWA, T., S. H. OH, L. PI, H. M. HATCH, T. SHUPE und B. E. PETERSEN (2005).
Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells.
Am J Pathol 166: 1781-1791.
GAGE, F. H. und A. BJÖRKLUND (1986).
Enhanced graft survival in the hippocampus following selective denervation.
Neuroscience 17: 89-98.
GALE, K. (1985).
Mechanisms of seizure control mediated by gamma-aminobutyric acid: role of the substantia nigra.
Fed Proc 44: 2414-2424.
GALE, K. (1988).
Progression and generalization of seizure discharge: anatomical and neurochemical substrates.
Epilepsia 29: 15-34.
GALE, K. (1992a).
GABA and epilepsy: basic concepts from preclinical research.
Epilepsia 33: 3-12.
GALE, K. (1992b).
Subcortical structures and pathways involved in convulsive seizure generation.
J Clin Neurophysiol 9: 264-277.
GALE, K. und M. J. IADAROLA (1980).
Seizure protection and increased nerve-terminal GABA: delayed effects of GABA transaminase inhibition.
Science 208: 288-291.
GALE, K., M. PROCTOR, J. VELÍŠKOVÁ und A. NEHLIG (2008).
Basal ganglia and brainstem anatomy and physiology. in: Epilepsy: a comprehensive textbook. Engel, J.J. and T. A. Pedley. Lippincott Williams & Wilkins, Philadelphia: 367-384.
GARANT, D. und K. GALE (1986).
Intranigral muscimol attenuates electrographic signs of seizure activity induced by intravenous bicuculline in rats.
Eur J Pharmacol 124: 365-369.
GARANT, D. S., S. G. XU, E. F. SPERBER und S. L. MOSHÉ (1995).
Age-related differences in the effects of GABAA agonists microinjected into rat substantia nigra: pro- and anticonvulsant actions.
Epilepsia 36: 960-965.
GARBELLI, R., F. INVERARDI, V. MEDICI, A. AMADEO, C. VERDERIO, M. MATTEOLI und C. FRASSONI (2008).
Heterogeneous expression of SNAP-25 in rat and human brain.
J Comp Neurol 506: 373-386.
172
GARBUZOVA-DAVIS, S., A. E. WILLING, M. MILLIKEN, S. SAPORTA, T. ZIGOVA, D. W.
CAHILL und P. R. SANBERG (2002).
Positive effect of transplantation of hNT neurons (NTera 2/D1 cell-line) in a model of familial amyotrophic lateral sclerosis.
Exp Neurol 174: 169-180.
GASIOR, M., N. A. WHITE und M. A. ROGAWSKI (2007).
Prolonged attenuation of amygdala-kindled seizure measures in rats by convection-enhanced delivery of the N-type calcium channel antagonists omega-conotoxin GVIA and omega-conotoxin MVIIA.
J Pharmacol Exp Ther 323: 458-468.
GERMAIN, N. D., N. W. HARTMAN, C. CAI, S. BECKER, J. R. NAEGELE und L. B. GRABEL (2012).
Teratocarcinoma Formation in Embryonic Stem Cell-Derived Neural Progenitor Hippocampal Transplants.
Cell Transplant 21: 1603-1611.
GERNERT, M., M. FEDROWITZ, P. WLAZ und W. LÖSCHER (2004).
Subregional changes in discharge rate, pattern, and drug sensitivity of putative GABAergic nigral neurons in the kindling model of epilepsy.
Eur J Neurosci 20: 2377-2386.
GERNERT, M. und W. LÖSCHER (2001).
Lack of robust anticonvulsant effects of muscimol microinfusions in the anterior substantia nigra of kindled rats.
Eur J Pharmacol 432: 35-41.
GERNERT, M., K. W. THOMPSON, W. LÖSCHER und A. J. TOBIN (2002).
Genetically engineered GABA-producing cells demonstrate anticonvulsant effects and long-term transgene expression when transplanted into the central piriform cortex of rats.
Exp Neurol 176: 183-192.
GIORDANO, M., H. TAKASHIMA, M. POLTORAK, H. M. GELLER und W. J. FREED (1996).
Constitutive expression of glutamic acid decarboxylase (GAD) by striatal cell lines immortalized using the tsA58 allele of the SV40 large T antigen.
Cell Transplant 5: 563-575.
GLIEN, M., C. BRANDT, H. POTSCHKA, H. VOIGT, U. EBERT und W. LÖSCHER (2001).
Repeated low-dose treatment of rats with pilocarpine: low mortality but high proportion of rats developing epilepsy.
Epilepsy Res 46: 111-119.
GRIFFITH, N., J. ENGEL, JR. und R. BANDLER (1987).
Ictal and enduring interictal disturbances in emotional behaviour in an animal model of temporal lobe epilepsy.
Brain Res 400: 360-364.
GROESBECK, D. K., R. M. BLUML und E. H. KOSSOFF (2006).
Long-term use of the ketogenic diet in the treatment of epilepsy.
Dev Med Child Neurol 48: 978-981.
173
GRÖTICKE, I., K. HOFFMANN und W. LÖSCHER (2007).
Behavioral alterations in the pilocarpine model of temporal lobe epilepsy in mice.
Exp Neurol 207: 329-349.
GRÖTICKE, I., K. HOFFMANN und W. LÖSCHER (2008).
Behavioral alterations in a mouse model of temporal lobe epilepsy induced by intrahippocampal injection of kainate.
Exp Neurol 213: 71-83.
GUILLEMAIN, I., G. ALONSO, G. PATEY, A. PRIVAT und I. CHAUDIEU (2000).
Human NT2 neurons express a large variety of neurotransmission phenotypes in vitro.
J Comp Neurol 422: 380-395.
GURDON, J. B. (1962).
The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles.
J Embryol Exp Morphol 10: 622-640.
HAGELL, P., P. PICCINI, A. BJÖRKLUND, P. BRUNDIN, S. REHNCRONA, H. WIDNER, L.
CRABB, N. PAVESE, W. H. OERTEL, N. QUINN, D. J. BROOKS und O. LINDVALL (2002).
Dyskinesias following neural transplantation in Parkinson's disease.
Nat Neurosci 5: 627-628.
HAMANI, C., J. A. SAINT-CYR, J. FRASER, M. KAPLITT und A. M. LOZANO (2004).
The subthalamic nucleus in the context of movement disorders.
Brain 127: 4-20.
HAMMOND, E. J. und B. J. WILDER (1985).
Gamma-vinyl GABA: a new antiepileptic drug.
Clin Neuropharmacol 8: 1-12.
HANDRECK, A., B. BACKOFEN-WEHRHAHN, S. BRÖER, W. LÖSCHER und M. GERNERT (2012).
Anticonvulsant effects by bilateral and unilateral transplantation of GABA-producing cells into the subthalamic nucleus in an acute seizure model.
Cell Transplant. 2012 (im Druck, DOI:10.3727/096368912X658944)
HARDMAN, C. D., J. M. HENDERSON, D. I. FINKELSTEIN, M. K. HORNE, G. PAXINOS und G.
M. HALLIDAY (2002).
Comparison of the basal ganglia in rats, marmosets, macaques, baboons, and humans: volume and neuronal number for the output, internal relay, and striatal modulating nuclei.
J Comp Neurol 445: 238-255.
HASEGAWA, T., D. KONDZIOLKA, S.-J. CHOI, J. BALZER, E.C. DIXON, W. FELLOWS-MAYLE und E. ELDER (2004).
Hippocampal neurotransplantation evaluated in the rat kainic acid epilepsy model.
Hippocampal neurotransplantation evaluated in the rat kainic acid epilepsy model.